.jpg)
.png)
All
JR is a 69-year-old white female with longstanding, well-controlled hypertension treated with an ACE-inhibitor who comes in for a cardiovascular risk evaluation. She denies a personal history of diabetes, tobacco abuse, psoriasis, collagen vascular disease, or chronic kidney disease. There is no... more
The National Lipid Association (NLA) today announced the publication of a new meta-analysis evaluating the impact of low-density lipoprotein cholesterol (LDL-C) lowering on major adverse cardiovascular events (MACE) in primary prevention populations. The study synthesizes data from randomized... more
A greater prevalence of dyslipidemia, insulin resistance, and atherosclerotic cardiovascular disease (ASCVD) and related-mortality are now well-recognized in South Asians living in the U.S. (SAUS), a fast-growing group that includes individuals from India, Pakistan, Bangladesh, Sri Lanka, Nepal,... more
Introduction Solid organ transplantation (SOT), encompassing kidney, liver, heart and to a lesser extent pancreas and lung, has become routine care for optimal treatment of end-stage disease in many patients.1,2 Refinements in transplantation protocols have helped preserve transplanted organs... more
Dr. Soffer: Greetings from Philadelphia. Dr. Saseen and I are very excited to be the new editors of the LipidSpin. Like many of you, I am a long-time reader and occasional contributor, and I consider it a great honor to be entrusted with this responsibility. As the editors, Joe and I are... more
The National Lipid Association (NLA) has named Matthew Ito, PharmD (’86), as its new president. Membership of the NLA includes physicians, pharmacists, researchers, nurses, physician assistants and dietitians. USC School of Pharmacy News – June 2013
The National Lipid Association's campaign for National Cholesterol Education Month is a social-media focused initiative to raise awareness about the importance of cholesterol management and its impact on cardiovascular health. Throughout September, the NLA will lead a social media campaign... more
Multiple randomized controlled trials have demonstrated significant reductions in major cardiovascular (CV) events and mortality with statin therapy.(1) These data have supported the “LDL-C treatment strategy,” in which CV event risk reduction is directly proportionate to the extent of... more
“None of us, including me, ever do great things. But we can all do small things, with great love, and together we can do something wonderful.” – Mother Teresa A collaborative leadership has the influence to transform health-systems and healthcare organizations, improving the system today and... more
We are sad to report that we learned last week that Dr. Roger Illingworth passed away in early November after a long illness. He was a founding member of the NLA Board. Dr. Illingworth’s career was dedicated to understanding, preventing and treating patients with cholesterol and lipid... more